This federal contract award, with ID SPE2DB22D1017 | SPE2DB25FF0MP, was issued by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, for the delivery of 4,566,612,711 units of the pharmaceutical product JARDIANCE 25 MG TABLET 90S. The contract has a firm fixed price of $3,843.38 and a completion date of December 5, 2024. The award was made on December 4, 2024 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider registered in the System for Award Management (SAM.gov) that specializes in supplying medical products to federal government agencies, particularly the DLA Troop Support Medical. This contract award is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Generated 3/5/25, 9:57 AM